Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Glassman Robert | Sep 15, 2026 | Sell | $331.72K | 8,667 |
| Chief Technical Ops Officer | Abele Stefan Andreas | Sep 15, 2026 | Sell | $1.72M | 45,000 |
| Chief Commercial Officer | Souverijns Wim | Sep 15, 2026 | Sell | $237.45K | 6,090 |
| Chief Technical Ops Officer | Abele Stefan Andreas | Sep 15, 2026 | Sell | $54.94K | 1,400 |
| CEO | Modig Berndt | Sep 14, 2026 | Sell | $90.28K | 2,291 |
| Chief Commercial Officer | Souverijns Wim | Sep 14, 2026 | Sell | $786.13K | 20,000 |
| President | Lu Peng | Sep 11, 2026 | Sell | $601.95K | 15,000 |
| Chief Early Development | Lesage Anne | Sep 10, 2026 | Sell | $1.15M | 30,000 |
| Director | Glassman Robert | Sep 9, 2026 | Sell | $300.4K | 8,000 |
| President | Lu Peng | Sep 8, 2026 | Sell | $610.13K | 15,000 |
| CEO | Modig Berndt | Aug 14, 2026 | Sell | $79.69K | 2,292 |
| CEO | Modig Berndt | Jul 13, 2026 | Sell | $80.15K | 2,292 |
| Director | Schikan Johannes Gerardus Christiaan Petrus | Jun 30, 2026 | Sell | $1.09M | 30,712 |
| Chief Early Development | Lesage Anne | Jun 30, 2026 | Sell | $988.89K | 27,872 |
| Chief Early Development | Lesage Anne | Jun 30, 2026 | Sell | $1.09M | 30,703 |
| Director | Schikan Johannes Gerardus Christiaan Petrus | Jun 29, 2026 | Sell | $241.45K | 6,888 |
| Director | Schikan Johannes Gerardus Christiaan Petrus | Jun 29, 2026 | Sell | $84.25K | 2,400 |
| Chief Early Development | Lesage Anne | Jun 29, 2026 | Sell | $80.79K | 2,300 |
| Chief Early Development | Lesage Anne | Jun 29, 2026 | Sell | $290.91K | 8,300 |
| Chief Early Development | Lesage Anne | Jun 29, 2026 | Sell | $245.23K | 6,997 |
| Chief Medical Officer | Lu Peng | Jun 26, 2026 | Sell | $499.85K | 14,700 |
| Chief Medical Officer | Lu Peng | Jun 25, 2026 | Sell | $399.67K | 11,600 |
| Chief Early Development | Lesage Anne | Jun 25, 2026 | Sell | $80.77K | 2,300 |
| Chief Medical Officer | Lu Peng | Jun 25, 2026 | Sell | $119.31K | 3,400 |
| Chief Early Development | Lesage Anne | Jun 25, 2026 | Sell | $80.79K | 2,300 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.